PALISADE BIO, INC.
Datakwaliteit: 83%
PALI
Nasdaq
Manufacturing
Chemicals
€ 1,95
▲
€ 0,08
(4,01%)
Marktkapitalisatie: 326,02 M
Prijs
€ 1,95
Marktkapitalisatie
326,02 M
Dagbereik
€ 1,88 — € 2,02
52-Weeksbereik
€ 0,53 — € 2,64
Volume
2.697.605
Openen € 1,88
50D / 200D Gem.
€ 1,79
8,59% above
50D / 200D Gem.
€ 1,48
31,78% above
Quick Summary
Belangrijkste Punten
Negative free cash flow of -10,85 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-575,48%
Onder sectorgemiddelde (-53,41%)
ROIC-460,73%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio1,96
Interest Coverage-1805,60
Waardering
PE (TTM)
-19,43
Onder sectorgemiddelde (-1,48)
P/B Ratio101,50
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -19,4 | -1,5 |
| P/B | 101,5 | 1,6 |
| ROE % | -575,5 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -16,78 M |
| ROE | -575,48% | ROA | -246,06% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -10,85 M |
| ROIC | -460,73% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1,96 |
| Interest Coverage | -1805,60 | Asset Turnover | N/A |
| Working Capital | 3,35 M | Tangible Book Value | 3,21 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -19,43 | Forward P/E | N/A |
| P/B Ratio | 101,50 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -3,33% | ||
| Market Cap | 326,02 M | Enterprise Value | 320,80 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,30 | Revenue / Share | N/A |
| FCF / Share | -0,06 | OCF / Share | -0,06 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 64,64% |
| SBC-Adj. FCF | -11,17 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | 0,0 | 250.000,0 | — | — |
| Net Income | -16,78 M | -14,44 M | -12,30 M | -14,26 M | -26,62 M |
| EPS (Diluted) | -0,30 | -10,19 | -1,80 | -16,53 | -3,39 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -18,06 M | -14,86 M | -13,07 M | -15,72 M | -41,85 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 16,00 M | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | 3.000,0 | 2.000,0 |
| Interest Expense | 10.000,0 | 12.000,0 | 15.000,0 | 13.000,0 | 2,40 M |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 134,34 M | 10,88 M | 14,05 M | 15,76 M | 12,51 M |
| Total Liabilities | 4,96 M | 3,39 M | 2,74 M | 3,28 M | 5,15 M |
| Shareholders' Equity | 129,38 M | 7,49 M | 11,31 M | 12,48 M | 7,37 M |
| Total Debt | — | — | — | — | 87.000,0 |
| Cash & Equivalents | 133,39 M | 9,82 M | 12,43 M | 12,38 M | 10,50 M |
| Current Assets | 134,22 M | 10,49 M | 13,33 M | 14,73 M | 12,37 M |
| Current Liabilities | 4,64 M | 3,24 M | 2,59 M | 3,01 M | 2,50 M |
{"event":"ticker_viewed","properties":{"ticker":"PALI","listing_kind":"stock","pathname":"/stocks/pali","exchange":"Nasdaq","country":"US"}}